sorafenib has been researched along with chrysin in 1 studies
Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (chrysin) | Trials (chrysin) | Recent Studies (post-2010) (chrysin) |
---|---|---|---|---|---|
6,520 | 730 | 5,251 | 913 | 6 | 646 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, LC; Chen, YJ; Chien, PH; Hsiang, YP; Hung, YJ; Pan, HL; Wei, CT | 1 |
1 other study(ies) available for sorafenib and chrysin
Article | Year |
---|---|
Chrysin-induced ERK1/2 Phosphorylation Enhances the Sensitivity of Human Hepatocellular Carcinoma Cells to Sorafenib.
Topics: Adenosine Triphosphate; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily G, Member 2; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Hep G2 Cells; Humans; Liver Neoplasms; Neoplasm Proteins; Phosphorylation; Sorafenib | 2019 |